Standout Papers
- Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia (2018)
- Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (2014)
- Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults (1988)
Immediate Impact
1 by Nobel laureates 26 from Science/Nature 70 standout
Citing Papers
New immune cell engagers for cancer immunotherapy
2024 Standout
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Works of H. Diedrich being referenced
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
2012
PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| H. Diedrich | 1374 | 1539 | 335 | 1235 | 34 | 2.7k | |
| Heinz‐August Horst | 1176 | 1485 | 299 | 1454 | 28 | 2.7k | |
| Christoph Faul | 1077 | 867 | 259 | 1249 | 82 | 2.4k | |
| Kheïra Beldjord | 1041 | 1084 | 373 | 520 | 54 | 2.5k | |
| Bernhard Kremens | 1527 | 879 | 377 | 770 | 83 | 3.5k | |
| Thorsten Raff | 1292 | 1418 | 577 | 610 | 32 | 2.5k | |
| Oumédaly Reman | 1871 | 1318 | 612 | 783 | 66 | 2.9k | |
| WD Ludwig | 1767 | 1763 | 433 | 913 | 47 | 3.4k | |
| Arend von Stackelberg | 1799 | 2169 | 258 | 898 | 90 | 3.2k | |
| Mihaela Onciu | 1917 | 1596 | 719 | 768 | 53 | 3.7k | |
| R Storb | 2608 | 542 | 592 | 830 | 47 | 3.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...